Press release
Biliary Atresia Market Projected to Reach USD 980 Million by 2034
Biliary Atresia Market
Introduction
Biliary atresia is a rare but serious pediatric liver disease in which bile ducts are blocked or absent, leading to liver damage and progressive cirrhosis. The condition usually presents in infants within the first few weeks of life, and without timely intervention, it can quickly become life-threatening.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71060
Currently, the Kasai portoenterostomy procedure and liver transplantation remain the cornerstone treatments. However, advances in early diagnostics, surgical techniques, immunosuppressive therapies, and regenerative medicine are reshaping the treatment landscape. Growing awareness, newborn screening programs, and increasing investments in pediatric liver research are expected to drive substantial growth in the biliary atresia market from 2024 to 2034.
Market Overview
• Market Size 2024: USD 310 Million
• Forecasted Market Size 2034: USD 980 Million
• CAGR (2025-2034): 12.4%
Key Highlights
• Rising incidence of biliary atresia globally, with higher prevalence in Asia-Pacific.
• Increasing number of pediatric liver transplants and improvements in survival outcomes.
• Expanding adoption of immunosuppressive and supportive drug therapies.
• Strong pipeline of regenerative and gene therapy research.
• Challenges include high treatment costs, donor organ shortages, and lack of awareness in low-income regions.
Market Segmentation
By Treatment Type
• Surgical Interventions
o Kasai Portoenterostomy
o Liver Transplantation
• Pharmacological Therapies
o Immunosuppressants
o Corticosteroids
o Bile Acid Modifiers
o Antivirals & Others
• Supportive Care
o Nutritional Supplements
o Vitamin Therapy
o Antibiotics
• Pipeline & Experimental Therapies
o Gene Therapy
o Regenerative Medicine (Stem Cell Therapy, Hepatocyte Transplantation)
By End Use
• Hospitals
• Specialty Clinics
• Pediatric Liver Care Centers
• Research & Academic Institutes
By Patient Demographic
• Infants (0-12 months)
• Children (1-12 years)
Segmentation Summary:
Surgical procedures remain the gold standard, with the Kasai operation performed early in life to delay or avoid transplantation. Liver transplantation is increasingly successful, supported by advanced immunosuppressants. Meanwhile, regenerative and gene therapies are the fastest-growing segments, holding promise for long-term disease modification.
Explore Full Report here: https://exactitudeconsultancy.com/reports/71060/biliary-atresia-market
Regional Analysis
North America
• Strong market share due to advanced transplant infrastructure and high healthcare expenditure.
• The U.S. leads in pediatric liver transplant programs and clinical research.
Europe
• High adoption of surgical and transplant therapies.
• Germany, France, and the UK are leaders in pediatric liver care and rare disease research.
Asia-Pacific
• Fastest-growing region, with higher prevalence of biliary atresia in countries like Japan, China, and Taiwan.
• Expanding newborn screening and improving healthcare access drive growth.
Middle East & Africa
• Limited infrastructure but improving liver care programs in Gulf nations.
• Lack of awareness remains a key barrier in most of Africa.
Latin America
• Brazil and Mexico emerging as key centers for pediatric liver care.
• Partnerships with international organizations expanding transplant access.
Regional Summary:
North America and Europe dominate in terms of advanced care, while Asia-Pacific is expected to post the highest CAGR (14.1%) through 2034, supported by growing awareness, higher incidence, and government-backed rare disease initiatives.
Market Dynamics
Growth Drivers
• Rising prevalence of biliary atresia globally.
• Advances in surgical techniques and transplant survival outcomes.
• Expansion of rare disease research funding and orphan drug incentives.
• Growing availability of pediatric liver care centers and specialists.
Key Challenges
• High cost of transplantation and long-term care.
• Global shortage of donor organs.
• Variability in treatment access across low- and middle-income countries.
• Limited availability of long-term curative therapies.
Latest Trends
• Development of gene therapies targeting underlying genetic risk factors.
• Increasing research into regenerative medicine to reduce transplant dependency.
• Adoption of AI-based diagnostic tools for early detection.
• Growth of cross-border collaborations for pediatric liver disease research.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71060
Competitor Analysis
Major Players
• Novartis AG
• Pfizer Inc.
• Gilead Sciences
• Johnson & Johnson
• Bristol Myers Squibb
• F. Hoffmann-La Roche Ltd.
• Takeda Pharmaceutical Company
• Vertex Pharmaceuticals
• Albireo Pharma (now part of Ipsen)
• Mirum Pharmaceuticals
Competitive Summary:
The biliary atresia market is driven by pharmaceutical and biotech innovation, with Albireo and Mirum leading in bile acid therapies. Novartis, Pfizer, and Takeda continue to expand research into pediatric rare diseases, while transplant centers partner with biotech companies to advance regenerative and gene therapy pipelines. Strategic collaborations with academic institutions remain key for accelerating progress.
Conclusion
The Biliary Atresia Market is expected to triple in value over the next decade, from USD 310 million in 2024 to USD 980 million by 2034, at a CAGR of 12.4%. The combination of advanced surgical interventions, growing pediatric liver transplant programs, and emerging gene and regenerative therapies will define the future of care. While donor shortages and cost remain challenges, expanding newborn screening, international collaboration, and biotech innovation are paving the way for transformative growth.
Key Takeaways:
• Market CAGR: 12.4% (2025-2034).
• Kasai surgery and liver transplantation remain cornerstones of treatment.
• Pharmacological therapies and supportive care play critical roles post-surgery.
• North America and Europe lead in infrastructure, Asia-Pacific posts the fastest growth.
• Gene therapy, regenerative medicine, and AI diagnostics represent the future of biliary atresia care.
This report is also available in the following languages : Japanese (胆道閉鎖症市場), Korean (담도폐쇄증 시장), Chinese (胆道闭锁市场), French (Marché de l'atrésie biliaire), German (Markt für Gallengangsatresie), and Italian (Mercato dell'atresia biliare), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/71060/biliary-atresia-market#request-a-sample
Our More Reports:
Breast Cancer Biomarker Market
https://exactitudeconsultancy.com/reports/71181/breast-cancer-biomarker-market
Bowen's Disease Market
https://exactitudeconsultancy.com/reports/71179/bowen-s-disease-market
Radiation induced-Oral Mucositis (RIOM) in Head and neck Cancer (HNC) Market
https://exactitudeconsultancy.com/reports/71177/radiation-induced-oral-mucositis-riom-in-head-and-neck-cancer-hnc-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biliary Atresia Market Projected to Reach USD 980 Million by 2034 here
News-ID: 4155945 • Views: …
More Releases from Exactitude Consultancy
Intracranial Hemorrhage (ICH) Market Growth, Trends, Consumer Demand and Key Opp …
Introduction
Intracranial hemorrhage (ICH) is a serious, life-threatening condition caused by bleeding within the brain tissue or ventricles. It may result from hypertension, trauma, aneurysms, arteriovenous malformations, or use of anticoagulants. As one of the deadliest subtypes of stroke, ICH accounts for high rates of morbidity and mortality worldwide, making it a critical focus area for healthcare providers and medical device manufacturers.
Growing global stroke prevalence, an aging population, and rising trauma…
Focal Segmental Glomerulosclerosis Market to Reach USD 1.62 Billion by 2034
Focal Segmental Glomerulosclerosis (FSGS) is a rare kidney disorder characterized by scarring (sclerosis) in parts of the glomeruli, which filter blood in the kidneys. This condition leads to proteinuria, nephrotic syndrome, and progressive renal failure if left untreated. FSGS can be primary (idiopathic) or secondary (linked to genetic mutations, obesity, hypertension, or infections).
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71062
Over the past decade, FSGS has gained increased recognition…
Brain Ischemia Market Set to Witness Significant Growth by 2025-2034
Introduction
Brain ischemia, also known as cerebral ischemia, occurs when blood flow to the brain is reduced or blocked, depriving it of oxygen and nutrients. It is one of the leading causes of stroke, disability, and death worldwide. The condition can result from blood clots, arterial blockages, or systemic circulatory issues, and requires immediate intervention to prevent long-term neurological damage.
With the growing global prevalence of stroke, rising geriatric populations, and increasing…
Aneurysmal Subarachnoid Hemorrhage (aSAH) Market Outlook 2025-2034
Introduction
Aneurysmal Subarachnoid Hemorrhage (aSAH) is a life-threatening neurological emergency caused by the rupture of an intracranial aneurysm, leading to bleeding in the subarachnoid space. It accounts for a significant proportion of hemorrhagic strokes and carries high rates of mortality and long-term disability. Prompt diagnosis and treatment are critical for patient survival, driving demand for advanced imaging, neurosurgical devices, and neurocritical care.
Growing incidence of hypertension, smoking, alcohol use, and age-related vascular…
More Releases for Biliary
Global Metal Pancreatic Biliary Stent Market Size by Application, Type, and Geog …
According to Market Research Intellect, the global Metal Pancreatic Biliary Stent market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The metal pancreatic biliary stent market is witnessing consistent growth due to the rising prevalence of…
Major Market Share Shift in Biliary Catheters Industry: Advancements In Biliary …
What Is the Forecasted Market Size and Growth Rate for the Biliary Catheters Market?
The market size for biliary catheters has experienced robust growth in recent years. There is an expected growth from $3.42 billion in 2024 to $3.75 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 9.7%. Factors like increased occurrences of biliary tract ailments, the popularity of minimally invasive procedures, a growing aging population, more…
Primary Biliary Cholangitis Treatment Market
Primary Biliary Cholangitis Treatment Market
Global Primary Biliary Cholangitis Treatment Market Expected to Reach US$ YY Million by 2030, Growing at a CAGR of YY%: Market Insights and Dynamics
The Global Primary Biliary Cholangitis Treatment Market, which reached US$ YY billion in 2022, is anticipated to achieve US$ YY million by 2030, exhibiting a robust CAGR of YY% during the forecast period from 2024 to 2031.
Primary Biliary Cholangitis (PBC), formerly known as…
Biliary Stents Market - Unleashing Flow: Empowering Biliary Health with Innovati …
Newark, New Castle, USA - new report, titled Biliary Stents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Biliary Stents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Biliary Stents market. The report offers an overview of the market, which…
High Prevalence of Biliary Diseases Across the Globe is Driving the Biliary Sten …
Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid.…
Rise in Surgical Procedures of Biliary Diseases is Expected to Boost the Biliary …
Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid.…
